BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35248746)

  • 1. The impact of the updated EORTC/MSG criteria on the classification of hematological patients with suspected invasive pulmonary aspergillosis.
    Lamberink H; Wagemakers A; Sigaloff KCE; van Houdt R; de Jonge NA; van Dijk K
    Clin Microbiol Infect; 2022 Aug; 28(8):1120-1125. PubMed ID: 35248746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy.
    Acet-Öztürk NA; Ömer-Topçu D; Vurat-Acar K; Aydın-Güçlü Ö; Pınar İE; Demirdöğen E; Görek-Dilektaşlı A; Kazak E; Özkocaman V; Ursavas A; Akalın H; Özkalemkaş F; Ener B; Ali R
    J Mycol Med; 2022 Nov; 32(4):101304. PubMed ID: 35738036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
    Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
    Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.
    Hardak E; Fuchs E; Leskes H; Geffen Y; Zuckerman T; Oren I
    Int J Infect Dis; 2019 Jun; 83():20-25. PubMed ID: 30926540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Galactomannan Tests of Bronchoalveolar Lavage Fluid for Diagnosing Invasive Pulmonary Aspergillosis].
    Deng J; Wu SY; Liu Y; Ma Y; Xie Y; Chen ZX; Dai ZQ; Deng JL; Kang M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):124-128. PubMed ID: 29737102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
    Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
    J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective Multicenter Evaluation of the VirClia Galactomannan Antigen Assay for the Diagnosis of Pulmonary Aspergillosis with Bronchoalveolar Lavage Fluid Samples from Patients with Hematological Disease.
    Buil JB; Huygens S; Dunbar A; Schauwvlieghe A; Reynders M; Langerak D; van Dijk K; Bruns A; Haas PJ; Postma DF; Biemond B; Delma FZ; de Kort E; Melchers WJG; Verweij PE; Rijnders B
    J Clin Microbiol; 2023 May; 61(5):e0004423. PubMed ID: 37097150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing Invasive Pulmonary Aspergillosis in Hematology Patients: a Retrospective Multicenter Evaluation of a Novel Lateral Flow Device.
    Mercier T; Schauwvlieghe A; de Kort E; Dunbar A; Reynders M; Guldentops E; Rijnders B; Verweij PE; Lagrou K; Maertens J
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30651395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: a prospective study in pediatric patients.
    Mohammadi S; Khalilzadeh S; Goudarzipour K; Hassanzad M; Mahdaviani A; Aarabi N; Pourabdollah M; Sigari N
    Med Mycol; 2015 Sep; 53(7):709-16. PubMed ID: 26229150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology.
    Thornton C; Johnson G; Agrawal S
    J Vis Exp; 2012 Mar; (61):. PubMed ID: 22473419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
    de Mol M; de Jongste JC; van Westreenen M; Merkus PJ; de Vries AH; Hop WC; Warris A; Janssens HM
    Pediatr Pulmonol; 2013 Aug; 48(8):789-96. PubMed ID: 22949309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review.
    Avni T; Levy I; Sprecher H; Yahav D; Leibovici L; Paul M
    J Clin Microbiol; 2012 Nov; 50(11):3652-8. PubMed ID: 22952268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the Results of Galactomannan and Beta Glucan Antigen Tests in the Suspicion of Invasive Pulmonary Aspergillosis].
    Çuhadar T; Kalkancı A; Tunçcan Güzel Ö; Yeğin ZA; Özkurt ZN; Köktürk N; Yağcı M
    Mikrobiyol Bul; 2023 Apr; 57(2):274-282. PubMed ID: 37067211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
    Danpornprasert P; Foongladda S; Tscheikuna J
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the galactomannan test for the diagnosis of invasive pulmonary aspergillosis using non-invasive proximal airway samples.
    Chun JY; Jeong SJ; Kim S; Choi S; Lee JH; Chung HS; Park S; Lee H; Kim HY; Hwangbo B; Choi YJ
    J Infect; 2024 Jun; 88(6):106159. PubMed ID: 38641139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.
    Hsu LY; Ding Y; Phua J; Koh LP; Chan DS; Khoo KL; Tambyah PA
    BMC Infect Dis; 2010 Mar; 10():44. PubMed ID: 20199673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis.
    Lim SY; Lee YW; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH; Kim SH
    Mycoses; 2021 Sep; 64(9):1124-1131. PubMed ID: 33740824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Park SY; Lee SO; Choi SH; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Koh Y; Kim YS; Woo JH; Kim SH
    J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sputum signatures for invasive pulmonary aspergillosis in patients with underlying respiratory diseases (SPARED): study protocol for a prospective diagnostic trial.
    Xiao W; Gong DY; Mao B; Du XM; Cai LL; Wang MY; Fu JJ
    BMC Infect Dis; 2018 Jun; 18(1):271. PubMed ID: 29890956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.